French Govt Announces List Of ‘Critical Medicines’ Amid Growing Shortage Problem
A priority list is one of the “urgent” measures the French pharma industry has called for as part of its contribution to the government’s 2023-25 roadmap for dealing with drug shortages, which is due to be published next month.
You may also be interested in...
Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.
The Danish drug regulator says its new critical medicines list and notification form will make it easier for companies to notify the agency of supply shortages.
Proposals for the overhaul of the EU pharmaceutical legislation will make medicines more widely available, accessible and affordable while supporting innovation and boosting the “competitiveness and attractiveness” of Europe’s pharma industry, the European Commission claims. The research-based industry thinks otherwise, saying cuts in regulatory protections will undermine R&D.